IL-17A is an important effector of the immune response of the mammary gland to Escherichia coli infection

Journal of Immunology

Volumn 196, Issue 2, 2016, Pages 803-812

  Porcherie, Adeline ^a   Gilbert, Florence B ^a   Germon, Pierre ^a   Cunha, Patricia ^a   Trotereau, Angelina ^a   Rossignol, Christelle ^a   Winter, Nathalie ^a   Berthon, Patricia ^a   Rainard, Pascal ^a  

^a UR1282   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CXCL2 CHEMOKINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL LOAD; BACTERIAL STRAIN; CELL COUNT; CELL MIGRATION; CELL TRANSPORT; CONTROLLED STUDY; ESCHERICHIA COLI INFECTION; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNITY; INOCULATION; LEUKOCYTE; MAMMARY GLAND; MASTITIS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; UDDER;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; MAMMARY GLANDS, ANIMAL; MASTITIS; MICE; MICE, INBRED C57BL;

EID: 84954165093     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500705     Document Type: Article

References (61)

1. Barbosa-Cesnik, C., K. Schwartz, and B. Foxman. 2003. Lactation mastitis. JAMA 289: 1609-1612.
2. Esslemont, D. 2011. Improving dairy cow welfare. Vet. Rec. 168: 433-434.
3. Hogan, J., and K. Larry Smith. 2003. Coliform mastitis. Vet. Res. 34: 507-519.
4. Dosogne, H., F. Vangroenweghe, and C. Burvenich. 2002. Potential mechanism of action of J5 vaccine in protection against severe bovine coliform mastitis. Ve t. Res. 33: 1-12.
5. Eberhart, R. J., R. P. Natzke, F. H. S. Newbould, B. Nonnecke, and P. Thompson. 1979. Coliform mastitis - A review. J. Dairy Sci. 62: 1-22.
6. Burvenich, C., D. D. Bannerman, J. D. Lippolis, L. Peelman, B. J. Nonnecke, M. E. Kehrli, Jr., and M. J. Paape. 2007. Cumulative physiological events influence the inflammatory response of the bovine udder to Escherichia coli infections during the transition period. J. Dairy Sci. 90(Suppl. 1): E39-E54.
7. Paape, M. J., D. D. Bannerman, X. Zhao, and J. W. Lee. 2003. The bovine neutrophil: structure and function in blood and milk. Vet. Res. 34: 597-627.
8. Rainard, P., and C. Riollet. 2006. Innate immunity of the bovine mammary gland. Vet. Res. 37: 369-400.
9. Porcherie, A., P. Cunha, A. Trotereau, P. Roussel, F. B. Gilbert, P. Rainard, and P. Germon. 2012. Repertoire of Escherichia coli agonists sensed by innate immunity receptors of the bovine udder and mammary epithelial cells. Vet. Res. 43: 14.
10. Yang, W., H. Zerbe, W. Petzl, R. M. Brunner, J. Günther, C. Draing, S. von Aulock, H. J. Schuberth, and H. M. Seyfert. 2008. Bovine TLR2 and TLR4 properly transduce signals from Staphylococcus aureus and E. Coli, but S. Aureus fails to both activate NF-kappaB in mammary epithelial cells and to quickly induce TNFalpha and interleukin-8 (CXCL8) expression in the udder. Mol. Immunol. 45: 1385-1397.
11. Bannerman, D. D. 2009. Pathogen-dependent induction of cytokines and other soluble inflammatory mediators during intramammary infection of dairy cows. J. Anim. Sci. 87(13Suppl.): 10-25.
12. Bannerman, D. D., M. J. Paape, J. W. Lee, X. Zhao, J. C. Hope, and P. Rainard. 2004. Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection. Clin. Diagn. Lab. Immunol. 11: 463-472.
13. Shuster, D. E., M. E. Kehrli, Jr., P. Rainard, and M. Paape. 1997. Complement fragment C5a and inflammatory cytokines in neutrophil recruitment during intramammary infection with Escherichia coli. Infect. Immun. 65: 3286-3292.
14. Riollet, C., P. Rainard, and B. Poutrel. 2000. Differential induction of complement fragment C5a and inflammatory cytokines during intramammary infections with Escherichia coli and Staphylococcus aureus. Clin. Diagn. Lab. Immunol. 7: 161-167.
15. Vangroenweghe, F., P. Rainard, M. Paape, L. Duchateau, and C. Burvenich. 2004. Increase of Escherichia coli inoculum doses induces faster innate immune response in primiparous cows. J. Dairy Sci. 87: 4132-4144.
16. Dernfalk, J., K. Persson Waller, and A. Johannisson. 2007. The xMAP technique can be used for detection of the inflammatory cytokines IL-1beta, IL-6 and TNF-alpha in bovine samples. Vet. Immunol. Immunopathol. 118: 40-49.
17. Anderson, J. C. 1983. The mouse mastitis model: observations relevant to the treatment and control of coliform mastitis. Vet. Res. Commun. 7: 223-227.
18. Elazar, S., E. Gonen, A. Livneh-Kol, I. Rosenshine, and N. Y. Shpigel. 2010. Essential role of neutrophils but not mammary alveolar macrophages in a murine model of acute Escherichia coli mastitis. Vet. Res. 41: 53.
19. Notebaert, S., D. Demon, T. Vanden Berghe, P. Vandenabeele, and E. Meyer. 2008. Inflammatory mediators in Escherichia coli-induced mastitis in mice. Comp. Immunol. Microbiol. Infect. Dis. 31: 551-565.
20. Modak, R., S. Das Mitra, P. Krishnamoorthy, A. Bhat, A. Banerjee, B. R. Gowsica, M. Bhuvana, V. Dhanikachalam, K. Natesan, R. Shome, et al. 2012. Histone H3K14 and H4K8 hyperacetylation is associated with Escherichia coli-induced mastitis in mice. Epigenetics 7: 492-501.
21. Kolls, J. K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
22. Weaver, C. T., L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
23. Happel, K. I., P. J. Dubin, M. Zheng, N. Ghilardi, C. Lockhart, L. J. Quinton, A. R. Odden, J. E. Shellito, G. J. Bagby, S. Nelson, and J. K. Kolls. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202: 761-769.
24. Aujla, S. J., P. J. Dubin, and J. K. Kolls. 2007. Th17 cells and mucosal host defense. Semin. Immunol. 19: 377-382.
25. Curtis, M. M., and S. S. Way. 2009. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126: 177-185.
26. Dubin, P. J., and J. K. Kolls. 2008. Th17 cytokines and mucosal immunity. Immunol. Rev. 226: 160-171.
27. Bruno, D. R., P. V. Rossitto, R. G. Bruno, M. T. Blanchard, T. Sitt, B. V. Yeargan, W. L. Smith, J. S. Cullor, and J. L. Stott. 2010. Differential levels of mRNA transcripts encoding immunologic mediators in mammary gland secretions from dairy cows with subclinical environmental Streptococci infections. Vet. Immunol. Immunopathol. 138: 15-24.
28. Riollet, C., D. Mutuel, M. Duonor-Cérutti, and P. Rainard. 2006. Determination and characterization of bovine interleukin-17 cDNA. J. Interferon Cytokine Res. 26: 141-149.
29. Tao, W., and B. Mallard. 2007. Differentially expressed genes associated with Staphylococcus aureus mastitis of Canadian Holstein cows. Vet. Immunol. Immunopathol. 120: 201-211.
30. Roussel, P., P. Cunha, A. Porcherie, W. Petzl, F. B. Gilbert, C. Riollet, H. Zerbe, P. Rainard, and P. Germon. 2015. Investigating the contribution of IL-17A and IL-17F to the host response during Escherichia coli mastitis. Vet. Res. 46: 56.
31. Bougarn, S., P. Cunha, F. B. Gilbert, A. Harmache, G. Foucras, and P. Rainard. 2011. Staphylococcal-associated molecular patterns enhance expression of immune defense genes induced by IL-17 in mammary epithelial cells. Cytokine 56: 749-759.
32. Gonen, E., A. Vallon-Eberhard, S. Elazar, A. Harmelin, O. Brenner, I. Rosenshine, S. Jung, and N. Y. Shpigel. 2007. Toll-like receptor 4 is needed to restrict the invasion of Escherichia coli P4 into mammary gland epithelial cells in a murine model of acute mastitis. Cell. Microbiol. 9: 2826-2838.
33. Bramley, A. J. 1976. Variations in the susceptibility of lactating and non-lactating bovine udders to infection when infused with Escherichia coli. J. Dairy Res. 43: 205-211.
34. Hill, A. W., A. L. Shears, and K. G. Hibbitt. 1979. The pathogenesis of experimental Escherichia coli mastitis in newly calved dairy cows. Res. Vet. Sci. 26: 97-101.
35. Rainard, P. 1983. Experimental mastitis with Escherichia coli: kinetics of bac-teriostatic and bactericidal activities. Ann. Rech. Vet. 14: 1-11.
36. Shpigel, N. Y., D. Levin, M. Winkler, A. Saran, G. Ziv, and A. Böttner. 1997. Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. J. Dairy Sci. 80: 318-323.
37. Lee, J. W., M. J. Paape, and X. Zhao. 2003. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice. Vet. Res. 34: 307-316.
38. Notebaert, S., H. Carlsen, D. Janssen, P. Vandenabeele, R. Blomhoff, and E. Meyer. 2008. In vivo imaging of NF-kappaB activity during Escherichia coli-induced mammary gland infection. Cell. Microbiol. 10: 1249-1258.
39. Chandler, R. L. 1970. Experimental bacterial mastitis in the mouse. J. Med. Microbiol. 3: 273-282.
40. Anderson, J. C. 1981. The effect of suckling on the course of experimental staphylococcal mastitis in the mouse. Br. Vet. J. 137: 489-500.
41. Porcherie, A., C. Mathieu, R. Peronet, E. Schneider, J. Claver, P. H. Commere, H. Kiefer-Biasizzo, H. Karasuyama, G. Milon, M. Dy, et al. 2011. Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria. J. Exp. Med. 208: 2225-2236.
42. Huber, S. A. 2009. Depletion of gammadelta+ T cells increases CD4+ FoxP3 (T regulatory) cell response in coxsackievirus B3-induced myocarditis. Immunology 127: 567-576.
43. Betts, R. J., A. W. Ho, and D. M. Kemeny. 2011. Partial depletion of natural CD4+CD25+ regulatory T cells with anti-CD25 antibody does not alter the course of acute influenza A virus infection. PLoS One 6: e27849.
44. Ma, S., J. A. Richardson, A. Bitmansour, T. D. Solberg, R. Pidikiti, K. Song, S. Stojadinovic, E. S. Vitetta, and J. J. Meyer. 2013. Partial depletion of regulatory T cells does not influence the inflammation caused by high dose hemi-body irradiation. PLoS One 8: e56607.
45. Li, L., L. Huang, A. L. Vergis, H. Ye, A. Bajwa, V. Narayan, R. M. Strieter, D. L. Rosin, and M. D. Okusa. 2010. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J. Clin. Invest. 120: 331-342.
46. Schnyder-Candrian, S., D. Togbe, I. Couillin, I. Mercier, F. Brombacher, V. Quesniaux, F. Fossiez, B. Ryffel, and B. Schnyder. 2006. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203: 2715-2725.
47. Ouyang, W., J. K. Kolls, and Y. Zheng. 2008. The biological function of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454-457.
48. Burvenich, C., V. Van Merris, J. Mehrzad, A. Diez-Fraile, and L. Duchateau. 2003. Severity of E. Coli mastitis is mainly determined by cow factors. Vet. Res. 34: 521-564.
49. Lockhart, E., A. M. Green, and J. L. Flynn. 2006. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177: 4662-4669.
50. Martin, B., K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen. 2009. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321-330.
51. Huber, S., N. Gagliani, and R. A. Flavell. 2012. Life, death, and miracles: Th17 cells in the intestine. Eur. J. Immunol. 42: 2238-2245.
52. Shen, F., and S. L. Gaffen. 2008. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 41: 92-104.
53. Chong, D. L., R. J. Ingram, D. E. Lowther, R. Muir, S. Sriskandan, and D. M. Altmann. 2012. The nature of innate and adaptive interleukin-17A responses in sham or bacterial inoculation. Immunology 136: 325-333.
54. Stein, T., J. S. Morris, C. R. Davies, S. J. Weber-Hall, M. A. Duffy, V. J. Heath, A. K. Bell, R. K. Ferrier, G. P. Sandilands, and B. A. Gusterson. 2004. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res. 6: R75-R91.
55. Clarkson, R. W., M. T. Wayland, J. Lee, T. Freeman, and C. J. Watson. 2004. Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res. 6: R92-R109.
56. Rutz, S., C. Eidenschenk, and W. Ouyang. 2013. IL-22, not simply a Th17 cy-tokine. Immunol. Rev. 252: 116-132.
57. Korn, T., M. Oukka, V. Kuchroo, and E. Bettelli. 2007. Th17 cells: effector T cells with inflammatory properties. Semin. Immunol. 19: 362-371.
58. Huber, S., N. Gagliani, E. Esplugues, W. O'Connor, Jr., F. J. Huber, A. Chaudhry, M. Kamanaka, Y. Kobayashi, C. J. Booth, A. Y. Rudensky, et al. 2011. Th17 cells express interleukin-10 receptor and are controlled by Foxp3+ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34: 554-565.
59. Rainard, P., P. Cunha, S. Bougarn, A. Fromageau, C. Rossignol, F. B. Gilbert, and P. Berthon. 2013. T helper 17-associated cytokines are produced during antigen-specific inflammation in the mammary gland. PLoS One 8: e63471.
60. Rainard, P., P. Cunha, M. Ledresseur, C. Staub, J. L. Touzé, F. Kempf, F. B. Gilbert, and G. Foucras. 2015. Antigen-Specific Mammary Inflammation Depends on the Production of IL-17A and IFN-g by Bovine CD4+ T Lymphocytes. PLoS One 10: e0137755.
61. Marks, B. R., and J. Craft. 2009. Barrier immunity and IL-17. Semin. Immunol. 21: 164-171.